Mass spectrometric study ofin vivo production of advanced glycation end-products/peptides

This publication has 17 references indexed in Scilit:

• Site-Specific Quantitative Evaluation of the Protein Glycation Product N⁶-(2,3-Dihydroxy-5,6-dioxohexyl)-l-lysinate by LC−(ESI)MS Peptide Mapping: Evidence for Its Key Role in AGE Formation
  Bioconjugate Chemistry, 2003
• The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 2001
• Advanced glycation end-products: a review
  Diabetologia, 2001
• Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: Evidence for preferential modification of IgG light chains
  Life Sciences, 1998
• Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
  Diabetologia, 1996
• Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
  Proceedings of the National Academy of Sciences, 1994
• Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD
  Kidney International, 1994
• Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
  The Lancet, 1994
• Advanced Glycosylation End Products in Continuous Ambulatory Peritoneal Dialysis Patients
  American Journal of Kidney Diseases, 1993
• Immunochemical Detection of Advanced Glycation End Products in Renal Cortex From STZ-Induced Diabetic Rat
  Diabetes, 1993